Please enable JavaScript to continue using this application.

Compare $FENC vs $INDP | Chartloom

Compare

$FENC vs $INDP

Fennec Pharmaceuticals Inc · Indaptus Therapeutics Inc

FENC

Fennec Pharmaceuticals Inc

INDP

Indaptus Therapeutics Inc

Compare $FENC vs $INDP

Comparing Fennec Pharmaceuticals Inc and Indaptus Therapeutics Inc

FENCFennec Pharmaceuticals Inc

INDPIndaptus Therapeutics Inc

FENCFennec Pharmaceuticals Inc

Market cap

$372M

P/E (TTM)

—

Forward P/E (NTM)

18.55x

Forward P/S (NTM)

4.23x

Rev growth (TTM)

77.8%

YTD performance

39.5%

52W performance

16.2%

FCF yield

-0.5%

INDPIndaptus Therapeutics Inc

Market cap

$284M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-8.4%

52W performance

-42.7%

FCF yield

-5.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FENC

INDP

Detailed metrics comparison

FENC

Fennec Pharmaceuticals Inc

INDP

Indaptus Therapeutics Inc

Market Cap

FENC$372M

INDP$284M

Enterprise Value

FENC$331M

INDP$277M

Price

FENC$10.71

INDP$2.51

P/E Ratio

FENCN/A

INDPN/A

P/S Ratio

FENC6.28x

INDP0.00x

EV/Sales

FENC5.59x

INDP0.00x

EV/EBITDA

FENC111.97x

INDP0.00x

P/B Ratio

FENC8.43x

INDP32.14x

P/FCF Ratio

FENCN/A

INDPN/A

EV/FCF

FENC-162.16x

INDP-18.83x

PEG Ratio

FENCN/A

INDPN/A

Forward P/E (NTM)

FENC18.55x

INDPN/A

Forward P/S (NTM)

FENC4.23x

INDPN/A

Revenue (TTM)

FENC$59M

INDP$0

Revenue Growth (YoY)

FENC77.8%

INDPN/A

Forward Rev Growth

FENC42.8%

INDP0.0%

Gross Margin (TTM)

FENC93.7%

INDP0.0%

Operating Margin (TTM)

FENC0.0%

INDP0.0%

EBITDA Margin (TTM)

FENC-1.9%

INDP0.0%

Net Margin (TTM)

FENC-5.5%

INDP0.0%

FCF Margin (TTM)

FENC-3.4%

INDPN/A

Net Income (TTM)

FENC$-3M

INDP$-15M

FCF (TTM)

FENC$-2M

INDP$-15M

EPS (TTM)

FENC-$0.09

INDP-$0.13

ROE (TTM)

FENC-678.0%

INDP-30275.0%

ROA (TTM)

FENC-486.0%

INDP-20348.0%

ROIC (TTM)

FENC-678.0%

INDP-30275.0%

Cash

FENC$41M

INDP$8M

Debt

FENC$0

INDP$0

Net Cash/Debt

FENC$41M

INDP$8M

Current Ratio (TTM)

FENC5.85x

INDP19.48x

Quick Ratio (TTM)

FENC5.36x

INDP18.82x

Debt/Equity (TTM)

FENC0.00x

INDP0.00x

Debt/Assets (TTM)

FENC0.0%

INDP0.0%

Interest Coverage (TTM)

FENCN/A

INDPN/A

Net Debt/EBITDA (TTM)

FENC0.00x

INDP0.00x

Beta

FENC1.21

INDP0.99

52W Performance

FENC16.2%

INDP-42.7%

YTD Performance

FENC39.5%

INDP-8.4%

% from 52W High

FENC-19.2%

INDP-57.9%

% from 52W Low

FENC89.6%

INDP172.8%

Asset Turnover (TTM)

FENC0.89x

INDP0.00x

FCF Yield (TTM)

FENC-0.5%

INDP-5.2%

Earnings Yield (TTM)

FENC-0.9%

INDP-5.4%

Dividend Yield (TTM)

FENCN/A

INDPN/A

Rule of 40

FENC74.4

INDP0.0

EV/GP/RG

FENC0.12

INDPN/A

Ticker research

View FENC research View INDP research

Metric	FENC Fennec Pharmaceuticals Inc	INDP Indaptus Therapeutics Inc
Market & Valuation
Market Cap	$372M	$284M
Enterprise Value	$331M	$277M
Price	$10.71	$2.51
P/E Ratio	N/A	N/A
P/S Ratio	6.28x	0.00x
EV/Sales	5.59x	0.00x
EV/EBITDA	111.97x	0.00x
P/B Ratio	8.43x	32.14x
P/FCF Ratio	N/A	N/A
EV/FCF	-162.16x	-18.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	18.55x	N/A
Forward P/S (NTM)	4.23x	N/A
Revenue & Growth
Revenue (TTM)	$59M	$0
Revenue Growth (YoY)	77.8%	N/A
Forward Rev Growth	42.8%	0.0%
Profitability
Gross Margin (TTM)	93.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	0.0%
Net Margin (TTM)	-5.5%	0.0%
FCF Margin (TTM)	-3.4%	N/A
Net Income (TTM)	$-3M	$-15M
FCF (TTM)	$-2M	$-15M
EPS (TTM)	-$0.09	-$0.13
ROE (TTM)	-678.0%	-30275.0%
ROA (TTM)	-486.0%	-20348.0%
ROIC (TTM)	-678.0%	-30275.0%
Financial Health
Cash	$41M	$8M
Debt	$0	$0
Net Cash/Debt	$41M	$8M
Current Ratio (TTM)	5.85x	19.48x
Quick Ratio (TTM)	5.36x	18.82x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.99
52W Performance	16.2%	-42.7%
YTD Performance	39.5%	-8.4%
% from 52W High	-19.2%	-57.9%
% from 52W Low	89.6%	172.8%
Efficiency & Yields
Asset Turnover (TTM)	0.89x	0.00x
FCF Yield (TTM)	-0.5%	-5.2%
Earnings Yield (TTM)	-0.9%	-5.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	74.4	0.0
EV/GP/RG	0.12	N/A
Ticker research	View FENC research	View INDP research

Valuation

P/S Ratio

INDP

0.00x

FENC

6.28x

EV/FCF

FENC

-162.16x

INDP

-18.83x

Growth & revenue

Revenue Growth TTM

FENC

77.8%

Forward Revenue Growth

FENC

42.8%

INDP

0.0%

Profitability & performance

Gross Margin

FENC

93.7%

INDP

0.0%

ROE

FENC

-678.0%

INDP

-30275.0%

FCF Yield %

FENC

-0.5%

INDP

-5.2%

52-Week Performance

FENC

16.2%

INDP

-42.7%

Detailed metrics comparison

FENC

Fennec Pharmaceuticals Inc

INDP

Indaptus Therapeutics Inc

Market Cap

FENC$372M

INDP$284M

Enterprise Value

FENC$331M

INDP$277M

Price

FENC$10.71

INDP$2.51

P/E Ratio

FENCN/A

INDPN/A

P/S Ratio

FENC6.28x

INDP0.00x

EV/Sales

FENC5.59x

INDP0.00x

EV/EBITDA

FENC111.97x

INDP0.00x

P/B Ratio

FENC8.43x

INDP32.14x

P/FCF Ratio

FENCN/A

INDPN/A

EV/FCF

FENC-162.16x

INDP-18.83x

PEG Ratio

FENCN/A

INDPN/A

Forward P/E (NTM)

FENC18.55x

INDPN/A

Forward P/S (NTM)

FENC4.23x

INDPN/A

Revenue (TTM)

FENC$59M

INDP$0

Revenue Growth (YoY)

FENC77.8%

INDPN/A

Forward Rev Growth

FENC42.8%

INDP0.0%

Gross Margin (TTM)

FENC93.7%

INDP0.0%

Operating Margin (TTM)

FENC0.0%

INDP0.0%

EBITDA Margin (TTM)

FENC-1.9%

INDP0.0%

Net Margin (TTM)

FENC-5.5%

INDP0.0%

FCF Margin (TTM)

FENC-3.4%

INDPN/A

Net Income (TTM)

FENC$-3M

INDP$-15M

FCF (TTM)

FENC$-2M

INDP$-15M

EPS (TTM)

FENC-$0.09

INDP-$0.13

ROE (TTM)

FENC-678.0%

INDP-30275.0%

ROA (TTM)

FENC-486.0%

INDP-20348.0%

ROIC (TTM)

FENC-678.0%

INDP-30275.0%

Cash

FENC$41M

INDP$8M

Debt

FENC$0

INDP$0

Net Cash/Debt

FENC$41M

INDP$8M

Current Ratio (TTM)

FENC5.85x

INDP19.48x

Quick Ratio (TTM)

FENC5.36x

INDP18.82x

Debt/Equity (TTM)

FENC0.00x

INDP0.00x

Debt/Assets (TTM)

FENC0.0%

INDP0.0%

Interest Coverage (TTM)

FENCN/A

INDPN/A

Net Debt/EBITDA (TTM)

FENC0.00x

INDP0.00x

Beta

FENC1.21

INDP0.99

52W Performance

FENC16.2%

INDP-42.7%

YTD Performance

FENC39.5%

INDP-8.4%

% from 52W High

FENC-19.2%

INDP-57.9%

% from 52W Low

FENC89.6%

INDP172.8%

Asset Turnover (TTM)

FENC0.89x

INDP0.00x

FCF Yield (TTM)

FENC-0.5%

INDP-5.2%

Earnings Yield (TTM)

FENC-0.9%

INDP-5.4%

Dividend Yield (TTM)

FENCN/A

INDPN/A

Rule of 40

FENC74.4

INDP0.0

EV/GP/RG

FENC0.12

INDPN/A

Ticker research

View FENC research View INDP research

Metric	FENC Fennec Pharmaceuticals Inc	INDP Indaptus Therapeutics Inc
Market & Valuation
Market Cap	$372M	$284M
Enterprise Value	$331M	$277M
Price	$10.71	$2.51
P/E Ratio	N/A	N/A
P/S Ratio	6.28x	0.00x
EV/Sales	5.59x	0.00x
EV/EBITDA	111.97x	0.00x
P/B Ratio	8.43x	32.14x
P/FCF Ratio	N/A	N/A
EV/FCF	-162.16x	-18.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	18.55x	N/A
Forward P/S (NTM)	4.23x	N/A
Revenue & Growth
Revenue (TTM)	$59M	$0
Revenue Growth (YoY)	77.8%	N/A
Forward Rev Growth	42.8%	0.0%
Profitability
Gross Margin (TTM)	93.7%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	0.0%
Net Margin (TTM)	-5.5%	0.0%
FCF Margin (TTM)	-3.4%	N/A
Net Income (TTM)	$-3M	$-15M
FCF (TTM)	$-2M	$-15M
EPS (TTM)	-$0.09	-$0.13
ROE (TTM)	-678.0%	-30275.0%
ROA (TTM)	-486.0%	-20348.0%
ROIC (TTM)	-678.0%	-30275.0%
Financial Health
Cash	$41M	$8M
Debt	$0	$0
Net Cash/Debt	$41M	$8M
Current Ratio (TTM)	5.85x	19.48x
Quick Ratio (TTM)	5.36x	18.82x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.99
52W Performance	16.2%	-42.7%
YTD Performance	39.5%	-8.4%
% from 52W High	-19.2%	-57.9%
% from 52W Low	89.6%	172.8%
Efficiency & Yields
Asset Turnover (TTM)	0.89x	0.00x
FCF Yield (TTM)	-0.5%	-5.2%
Earnings Yield (TTM)	-0.9%	-5.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	74.4	0.0
EV/GP/RG	0.12	N/A
Ticker research	View FENC research	View INDP research